Sun Pharma Advanced Research Company Ltd Net Loss is INR -56.72 crores in Q4 FY 2020-2021

Sun Pharma Advanced Research Company Ltd Q3 FY20-21 Quarter Result { “@context”: “https://schema.org”, “@type”: “NewsArticle”, “Stock”: Sun Pharma Advanced Research Company Ltd, “Quarter Result”: “December 2020”, “Sales”: 28.06 cr, “Net Profit”: -56.72 cr }

Sun Pharma Advanced Research Company Ltd Net Loss is INR -56.72 crores in Quarter 4, January – March of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Sun Pharma Advanced Research Company Ltd Quarter Net Loss is widen by -43 % from Last Year Quarter and Net Loss of INR -56.72 crores is reported in Quarter 4, January – March of Financial Year 2020-2021. Last Year Quarter 4, January – March of Financial Year 2019-2020sa Net Loss was INR -99.54 crores.

Quarterly Net Sales Year-on-Year

Sun Pharma Advanced Research Company Ltd Quarter Sale is up 24 % from Last Quarter. Sales of 28.06 is reported in Quarter 4, January – March of Financial Year 2020-2021. In Last Year Quarter 4, January – March of Financial Year 2019-2020 Sale was 22.71

Annual Sales & Net Earning

Sun Pharma Advanced Research Company Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 76.81 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR -312.4 crores.


Sun Pharma Advanced Research Company Ltd Stock Information

SectorMiscellaneous
IndustryMiscellaneous
AboutSun Pharma Advanced Research Company is in the business of research & development of pharmaceutical products.
Latest Qaurter EPS-2.1644927012756177

Sun Pharma Advanced Research Company Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Sun Pharma Advanced Research Company Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *